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Abstract.  Colorectal carcinoma ranks third among ten leading causes of cancer in Malaysia.
The colorectal carcinoma tumourigenesis involves the inactivation of tumour suppressor
genes, and activation of proto-oncogenes. The p53 is one of the tumour suppressor genes that
is involved in the colorectal carcinogenesis. The p53 gene is located on human chromosome
17p13.1 and comprises of 11 exons. Deficiencies in the p53 gene can cause the cancerous
cells to spread to distant organs such as liver, lungs, lymph nodes, spine and bone. The most
common p53 abnormalities that can lead to the metastasis of colorectal tumours are mutation
and deregulation of the gene. In this study, nine colorectal carcinoma samples were used to
establish a simple and sensitive strategy in the study on in vivo p53 expression by using real-
time LightCycler SYBR Green I technology.
INTRODUCTION
In Malaysia, colorectal carcinoma is the
third leading cause of cancer in the
population (Lim & Halimah, 2003).
Colorectal carcinoma develops through a
cascade of histopathological and genetic
defects, which is known as adenoma to
carcinoma sequence (Kinzler & Vogelstein,
1996). The p53  genetic aberration is
involved in the late stage of colorectal
tumourigenesis (Vogelstein & Kinzler,
1996). This tumour suppressor gene has
been mapped to human chromosome
17p13.1 and it plays an important role in
cellular growth control (McBride et al.,
1986). Under stress condition, the wild
type p53 binds to DNA, stimulates
transcription of several genes and
mediates cell cycle arrest in the G1 phase
for DNA repair or initiates apoptosis when
the damaged DNA cannot be successfully
repaired (Kumudini et al., 2002). If the p53
gene is mutated, the damaged DNA
remains unrepaired and mutations become
fixed in the dividing cells. Subsequently,
malignant transformation of the cancerous
cells occurs and starts to accumulate the
mutated p53 gene (Kumudini et al., 2002).
Consequently, mutations and de-
regulation of the p53 gene are commonly
found in cancers (Wunderlich et al., 2000).
More than 75% of colorectal carcinomas
are due to mutation in the p53 gene (Erhan
et al., 2002), while over-expression of
the gene is associated with advanced
malignancies (Auvinen et al., 1994). Recent
preliminary reports revealed that over-
expression of p53 are an indicator of poor
prognosis and survival in the patient
(Remvikos et al., 1992; Sun et al., 1992;
Zhao et al., 2005). However, other reports
correlated low expression of the p53 gene
and adverse outcome (Kumudini et al.,
2002). Whether p53 expression level is
associated with patient survival and stages
of the diseases in colorectal tumour is still
uncertain and remains to be scrutinized.
